American Academy of Dermatology launches innovative project to improve outcomes for patients with life-threatening pustular psoriasis
American Academy of DermatologyThe American Academy of Dermatology, with critical support from Boehringer Ingelheim, and powered by OM1’s data aggregation system and its PhenOM™ artificial intelligence (AI) platform, is launching an innovative breakthrough project to develop educational resources to improve the evaluation, diagnosis, and treatment of patients suffering from generalized pustular psoriasis (GPP), a rare form of psoriasis that causes widespread, pus-filled blisters, called pustules.